🇺🇸 FDA

Drug profile · INN

edaravone

RADICAVA

FDA: approved EMA: application withdrawn TGA: approved PMDA: approved N07
US status
approved
Patents linked
0
News articles
0

Quick answer

edaravone (RADICAVA) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN edaravone
Brand RADICAVA
Route ORAL
Formulation INJECTABLE
ATC code N07
Originator Lacuna Pharma Pty Ltd

Frequently asked questions

What is edaravone?

edaravone (RADICAVA) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for edaravone?

RADICAVA is a marketed brand name for edaravone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of edaravone?

edaravone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.